熱門資訊> 正文

RadNet的DeepHealth通过TechLive获得FDA批准

2025-08-07 21:11

DeepHealth, a unit of RadNet (NASDAQ:RDNT), announced that it has received FDA clearance for TechLive, a new remote scanning solution.
TechLive is designed to work with various imaging technologies, allowing for remote scanning of MR, CT, PET/CT, and ultrasound procedures.
RDNT stock is down 24% YTD.

More on RadNet

iCAD Merger Arbitrage: Low-Risk Returns From A Game-Changing AI Imaging Acquisition
RadNet, Inc. (RDNT) Q1 2025 Earnings Call Transcript
RadNet secures $100M incremental term loan
Key deals this week: Qualcomm, Chart Industries, RadNet, AMD and more
Seeking Alpha’s Quant Rating on RadNet

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。